Navigation Links
MedTRACK Unveils Partnering Tool for J.P. Morgan Healthcare Conference
Date:12/21/2011

NEW YORK, Dec. 21, 2011 /PRNewswire/ -- MedTRACK, an Informa business unit, and the world's leading provider of pharmaceutical-focused business intelligence, has recently unveiled a premier partnering tool for the J.P. Morgan Healthcare Conference. The partnering filter helps delegates attending the conference find licensing, investment and acquisition opportunities.

With the new MedTRACK Partnering Filter companies can quickly identify like-minded suitors in terms of product development sorted by therapy area, stage of development, mechanism of action and a host of additional search parameters. The partnering filter drastically reduces time spent on initial screening and can quickly identify the companies that are best suited for partner discussions or investment opportunities.

As part of the product roll out MedTRACK is offering conference delegates an opportunity to test drive the partner tool to see first-hand the value MedTRACK Partnering Filter can add to their business development discussions.

About J.P. Morgan Healthcare Conference
The J.P. Morgan 30th Annual Healthcare Conference will be held from January 9th to January 12th 2012 in San Francisco, CA. The four day conference features presentations from several hundred companies both private and public.

About MedTRACK
MedTRACK is the leader in commercial and scientific intelligence for the life-science industry. MedTRACK combines a multitude of datasets into a single, integrated platform that allows clients to quickly search and analyze data. With MedTRACK, you will spend less time looking for information, and more time supporting the strategic decisions that are critical to your business. To find out more about MedTRACK go to www.medtrack.com 

To find out more about MedTRACK and how you can leverage the J.P.Morgan filter call (570) 687-9318 in the U.S, or +44 (0) 20 7551 9622 internationally.

For further information, call:
US: (570) 687-9312
Europe: +44 (0) 20 7551 9622
Asia-Pacific: +61 2 8705 6900
Japan: +81 3 5148 7670


'/>"/>
SOURCE MedTRACK
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011
2. Touch Bionics unveils innovative partner and reimbursement programs at AOPA
3. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
4. FBI unveils science of anthrax investigation
5. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
6. McMaster University unveils worlds most advanced microscope
7. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
8. Video: Insulet Unveils Video Contest for OmniPod Users
9. FBI unveils science of anthrax investigation
10. DuPont Unveils New Strategy to Expand its Seed Business
11. Medicsight Unveils New Version of ColonCAD(TM) at ECR 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016   Acuant , ... verification solutions, has partnered with RightCrowd ® ... for Visitor Management, Self-Service Kiosks and Continuous ... that add functional enhancements to existing physical ... and venues with an automated ID verification ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):